NCT03776903View on ClinicalTrials.gov

Evaluation of the Clinical Performance of the ZIKV Detect™ 2.0 IgM Capture ELISA

CompletedOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

April 1, 2018

Primary Completion Date

August 31, 2018

Study Completion Date

September 30, 2018

Conditions
Zika Virus Infection
Interventions
OTHER

ZIKV Detect™ 2.0 IgM Capture ELISA

De-identified archive specimens are tested by ELISA and compared to reference testing (RT-PCR and CDC MAC-ELISA)

Trial Locations (1)

98109

InBios International, Seattle

Sponsors
All Listed Sponsors
collaborator

Fast-Track Drugs & Biologics, LLC

UNKNOWN

collaborator

Biomedical Advanced Research and Development Authority

FED

lead

InBios International, Inc.

INDUSTRY

NCT03776903 - Evaluation of the Clinical Performance of the ZIKV Detect™ 2.0 IgM Capture ELISA | Biotech Hunter | Biotech Hunter